Insider Transactions
| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 25, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 8,588 | -- | -- |
| Jan 28, 2022 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,781 | $0.25 | 144,795 |
| Feb 18, 2020 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,946 | $0.25 | 108,338 |
| Feb 02, 2009 |
SVP and CFO
|
SVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,703 | $0.25 | 12,793 |
| Feb 02, 2024 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,813 | -- | 23,894 |
| Feb 02, 2024 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,813 | $0.25 | 195,520 |
| Feb 12, 2024 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 10,390 | $0.25 | 211,050 |
| Feb 03, 2023 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,178 | $0.25 | 169,341 |
| Jan 29, 2021 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 11,991 | $0.25 | 120,329 |
| Feb 02, 2021 |
EVP and CFO
|
EVP and CFO | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 12,152 | $0.25 | 132,481 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.